Sylwia Bujkiewicz

Professor of Biostatistics at the University of Leicester, She/her. Views my own. European. 🇪🇺🇵🇱🇬🇧

[Sylwia Bujkiewicz @SBujkiewicz]

Our new TSD on Multivariate meta-analysis and surrogate endpoints, for ⁦@NICE_DSU⁩ by ⁦@SBujkiewicz⁩ ⁦@AchanaFelix⁩ ⁦@TPapanick⁩ ⁦@Richard_D_Riley⁩ ⁦@KRAbrams⁩ is out.
More info and TSD here: https://t.co/DpmJpOZwJ3 https://t.co/OXUUmbwnye

[SPIRIT|CONSORT-SURROGATE @Consort_surr]

📢📢TWO NEW and #OpenAccess publications in @bmj_latest as a culmination of the SPIRIT|CONSORT-Surrogate project.

CONSORT-Surrogate: https://t.co/ji7584vmXI

SPIRIT-Surrogate: https://t.co/9hp1lag8BL

Please share or RT for awareness
🧵

[Nick Shrine @nickshrine]

#PLOSONE: Frank Dudbridge proposes an objective framework for statistical evidence, including the first logical argument for p<0.05 as a significance threshold https://t.co/ei1VuRTDo8

[Young Statisticians' Meeting 2025 @ysm_conference]

Make sure you are the first to hear about pre-conference courses, abstract submission and our fantastic plenary speakers by registering your interest on our website!

#YSM2024 @statsyss

https://t.co/wyFADqtwxS

[Sylwia Bujkiewicz @SBujkiewicz]

📢 New paper with @WheatonLorna and @danj_statsguru Well done Lorna!
Bayesian meta‐analysis for evaluating treatment effectiveness in biomarker subgroups using trials of mixed patient populations - Wheaton - Research Synthesis Methods https://t.co/X0HteJv3Yj

[Mark Sculpher @MJSculpher]

Great opportunity for research collaboration and to spend some time in York!

[Sylwia Bujkiewicz @SBujkiewicz]

PhD opportunity - deadline approaching

[Sylwia Bujkiewicz @SBujkiewicz]

4-year PhD in Biostatistics with me, ⁦@Richard_D_Riley⁩ and ⁦@leicestermedic⁩ and partners: ⁦@danj_statsguru⁩ and JSingh on methods (Bayesian, meta-analysis, risk prediction) in HTA oncology, for candidates with MSc Stats, deadline 12 Jan 2024
https://t.co/AxWEo7Y3QU

[Sylwia Bujkiewicz @SBujkiewicz]

4-year PhD in Biostatistics with me, ⁦@Richard_D_Riley⁩ and ⁦@leicestermedic⁩ and partners: ⁦@danj_statsguru⁩ and JSingh on methods (Bayesian, meta-analysis, risk prediction) in HTA oncology, for candidates with MSc Stats, deadline 12 Jan 2024
https://t.co/AxWEo7Y3QU

[Sylwia Bujkiewicz @SBujkiewicz]

📢NEW paper in @JClinEpi IPD informed and improved precision in the evaluation of predictive biomarkers in Bayesian NMA. With Chinyereugo @WheatonLorna @HeatherPoad @Ilse_Cuevas_A Devleena @leicestermedic Paul @KRAbrams @RhiannonKOwen https://t.co/iY7j6ihHnP

[PPIE for better statistical methodology research @Stats_PPIE]

📜PAPER📜Great to see our survey of statisticians about PPIE attitudes and practices published in Research Involvement and Engagement - thanks to all those who took part, really interesting insights! https://t.co/BaGy8ViYXe

[Richard Riley (R²) @Richard_D_Riley]

** NEW paper in @JClinEpi **

"Open science practices need substantial improvement in prognostic models in oncology using machine learning"

open access https://t.co/EDAdbxPqCf

Only 11 studies (24%) provided sufficient information to allow their model to be used in practice 🤯

[SPIRIT|CONSORT-SURROGATE @Consort_surr]

📢NEW Publication in @eClinicalMed as part of the SPIRIT|CONSORT-Surrogate Project

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials

https://t.co/TGpLQ2wJmD

[NICE DSU @NICE_DSU]

This month sees the next
@NICEComms/@NICE_DSU/@ABPI_UK
Masterclass Programme for 2023 - Methods for the analysis of non-randomised, patient level data for the estimation of treatment effects To find out more about it and how to register, visit: https://t.co/1rEBTX4fze

[Richard Riley (R²) @Richard_D_Riley]

New course dates & booking open

[ISCB_info @ISCB_info]

Lisa McShane’s keynote lecture at #ISCB44 about statistical adventures in the pursuit of precision medicine. Please share your thoughts and comments!
@IBS_Italian_Reg

[Sylwia Bujkiewicz @SBujkiewicz]

It was a pleasure to give an invited talk at the 9th Chanel Network Conference in Wageningen last week. Great mix of topics and lovely location. https://t.co/dFSjWlbv2Z

[Sylwia Bujkiewicz @SBujkiewicz]

Deadline approaching: Research Associate/Assistant

[Sylwia Bujkiewicz @SBujkiewicz]

Job: Bayesian evidence synthesis and real world evidence. Join me and a multi-institutional team including @KRAbrams @RhiannonKOwen @DrTerryQuinn Paul Tappenden and Katy Cooper for ~12 months in a MRC methods project

[Richard Riley (R²) @Richard_D_Riley]

*** Open for booking ***

"Statistical Methods for Meta-Analysis of Individual Participant Data"

3-day course, practicals in Stata or R

1-stage & 2-stage models for examining treatment effects, effect modifiers, test accuracy, prediction models & more

https://t.co/t4wDnmT9Wk

[Sylwia Bujkiewicz @SBujkiewicz]

Job: Bayesian evidence synthesis and real world evidence. Join me and a multi-institutional team including @KRAbrams @RhiannonKOwen @DrTerryQuinn Paul Tappenden and Katy Cooper for ~12 months in a MRC methods project

[UoL Population Health Sciences @UoL_Health_Sci]

JOBS | Res Asst or Res Assoc within MRC-funded evidence synthesis methodology project, FT/PT (min 0.5FTE) fixed term contract currently avail to 30/9/24 funded by MRC Closes 31 July @SBujkiewicz @UoL_Biostats
https://t.co/IZmfBbG6zQ

[Michael Sweeting @michaelsweeting]

I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code.
Huge thanks to
@MJRutherford9 @danj_statsguru @NRLatimer @pclambert123 and all co-authors
https://t.co/2sq41tNjNz

[HTAi @HTAiOrg]

Save the date! 🗓️

We are excited to announce the HTAi 2024 Annual Meeting is heading to Seville, Spain on June 16-19, 2024!

@AETSA_ #HTAi2024Seville